Biohit has Been Granted a U.S. Patent for an Invention of Binding Carcinogenic Acetaldehyde in Gastrointestinal Tract and in Nutrition

Published: Oct 16, 2012

Helsinki Stock Exchange, 2012-10-16 17:00 CEST (GLOBE NEWSWIRE) -- Biohit Oyj, Stock exchange Release 16th October 2012, at 18:00 EET - Biohit Oyj has been awarded US patent 8,227,513 B2, which is valid until 3.4.2026.

Back to news